Decibel Bio
PrivateLast Round
Series A
Mar 5, 2025
Est. Valuation
$109M
Total Funding Raised
$246.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Decibel Bio is an agricultural biotechnology company that develops a proprietary platform to read and write the plant epigenome, enabling real-time trait enhancements for crops without altering their DNA.
Sector
Frontier & Industrial Tech
Verticals
Biotechnology, Environmental Monitoring, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Decibel Bio Comparables
Compare Decibel Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aferna Bio | 80% | |
| Epicrop Technologies | 73% | |
| Tropic Biosciences | 71% |
Decibel Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 5, 2025 | ||||
| M&A | Sep 25, 2023 | ||||
| IPO | Feb 11, 2021 | ||||
| Series D | Nov 9, 2020 | ||||
| Series C | Jun 19, 2018 | ||||
Series B | Nov 15, 2017 |
Decibel Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | Series D |
| Janus Henderson Group | Series D |
| Fall Line Capital | Series A |
| Future Ventures | Series A |
| GV | Series C, Series B, Series D |
| OrbiMed | Series D |
| Breakthrough Energy Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors grew 388% MoM, from 315 to 1.5K.
- Apr 20, 2026
Monthly visitors increased 55% MoM.
Decibel Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Decibel Bio's valuation, stock price, and market status.
Is Decibel Bio a public or private company?
Decibel Bio is a private company.
What is the current stock price of Decibel Bio?
Decibel Bio is a private company, so its shares have no public market price. Caplight tracks Decibel Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Decibel Bio worth (valuation)?
Decibel Bio's valuation is estimated at $109.0M based on funding round data.
Can I buy Decibel Bio stock?
Decibel Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Decibel Bio's last funding round?
Decibel Bio's most recent funding round was Series A on March 5, 2025.
Who are the main investors in Decibel Bio?
Key investors in Decibel Bio include OrbiMed, Breakthrough Energy Ventures, Third Rock Ventures.
Will Decibel Bio IPO soon?
No public IPO plans have been announced for Decibel Bio.
How can I track Decibel Bio secondary market activity?
Caplight tracks bids, offers, and trades in Decibel Bio's shares on secondary markets.